Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
Makoto NaganumaShinya SugimotoTomohiro FukudaKeiichi MitsuyamaTaku KobayashiNaoki YoshimuraHidehisa OhiShinji TanakaAkira AndohNaoki OhmiyaKeiichiro SaigusaTakayuki YamamotoYuichi MorohoshiHitoshi IchikawaKatsuyoshi MatsuokaTadakazu HisamatsuKenji WatanabeShinta MizunoTakayuki AbeYasuo SuzukiTakanori Kanainull nullPublished in: Journal of gastroenterology (2019)
In a sub-analysis of data from a randomized placebo-controlled trial, we found that IN may be useful even in patients with steroid-dependent disease and patients with the previous use of anti-TNF-α.